Santé & Bien-être

Mindfulness Shows Promise in Digital Cannabis Self-Help

Ajouter MyCannabis.com à vos sources préférées sur Google

Can an online programme help people change their cannabis habits after its lessons end? That is a more demanding question than whether participants use less cannabis while actively working through exercises. Lasting change means carrying new skills into ordinary evenings, stressful workdays, and familiar situations that once prompted consumption.

A randomized trial published in Internet Interventions tested whether adding mindfulness to digital cannabis self-help could make those changes more durable.1 The results suggest it might. Six months after enrolment, the mindfulness-enhanced programme outperformed standard digital cognitive behavioural therapy on cannabis-use frequency. However, substantial missing follow-up data means this is a promising direction for research, not a settled treatment claim.

Why Mindfulness Might Help Change Cannabis Habits

Cognitive behavioural therapy, usually shortened to CBT, helps people recognize connections between thoughts, feelings, and actions. In cannabis self-help, that can mean identifying consumption triggers, planning alternative responses, and learning how to handle cravings.

Mindfulness adds deliberate, nonjudgmental attention to present experiences. Someone might learn to notice an urge, observe its physical sensations, and let it change without immediately acting. The researchers discuss “urge surfing”: treating a craving like a passing wave rather than an instruction that must be followed.

The distinction is practical. Recognizing that a difficult evening triggers consumption is useful; developing a different response during that evening may require repeated practice. Mindfulness could help bridge that gap, although the trial did not establish which psychological mechanism produced its results.

Context also matters. MyCannabis’s recent coverage of solitary cannabis use and loneliness illustrates how consumption and emotional experiences can overlap without proving which causes which. Effective support needs room for that complexity.

How the CANreduce Trial Tested Digital Self-Help

Researchers randomly assigned 301 adults to mindfulness-enhanced CANreduce, standard CANreduce, or a waitlist control. Participants needed to use cannabis at least weekly and understand German. In practice, the sample reported cannabis use on approximately 26 of the previous 30 days at baseline.

Both active programmes contained eight modules delivered over six weeks, with CBT and motivational interviewing elements. The mindfulness version added practices such as guided meditation and body scans. Participants could continue accessing exercises after the six-week programme. The standard version offered comparable text lengths but no mindfulness or audio practices.

The programmes were fully automated, without clinical oversight. Waitlisted participants received brief risk information and harm-reduction resources, retained access to usual care, and were offered the mindfulness programme after the final assessment.

Including an active comparison strengthens the design. The researchers could ask whether the enhanced package added value beyond an existing programme, rather than simply comparing structured help with waiting. However, because audio exercises also differed between programmes, the comparison cannot isolate mindfulness content from every difference in delivery.

What Changed After Six Months?

At six weeks, both active programmes reduced cannabis-use days relative to the control group, with no significant difference between them. The more consequential separation appeared later.

At six months, the main statistical analysis estimated 48% fewer cannabis-use days in the mindfulness group than in the standard group, and 54% fewer than in the control group. These percentages compare groups at follow-up; they do not describe reductions from each participant’s starting level.

The mindfulness group also had better depression and anxiety symptom scores than both comparators. Standard CANreduce no longer differed significantly from the control on use days, but it still showed benefits on some other measures, including cannabis quantity and cannabis-related problems. Its effects had not simply disappeared.

Key Findings From the CANreduce Trial
Finding Meaning Limitation
Both programmes improved use frequency at six weeks Both offered an early advantage over the control No significant difference between active programmes then
Six-month mindfulness versus standard use-day ratio: 0.52 Model estimated 48% fewer use days Results depend on missing-data assumptions
Depression and anxiety scores favoured mindfulness at six months Benefits extended beyond consumption frequency Symptoms were self-reported
95 of 301 participants completed six-month follow-up Final retention was 31.6% Most participants had no observed final assessment

Why Missing Follow-Up Data Matters

Imagine evaluating a course when only about one-third of students return the final questionnaire. Their answers may be encouraging, but what happened to everyone else becomes central to interpreting the result.

The researchers used multiple imputation, a statistical approach that estimates missing observations using available information. They also analysed participants with observed data and tested how unfavourable missing outcomes would need to be to overturn the main finding. Those checks supported the six-month advantage, although its size varied.

These safeguards strengthen confidence without recovering the missing experiences. If people stopped responding because they relapsed or disliked the programme, assumptions about their outcomes could still matter. Recruitment also stopped at 301 participants rather than the planned 630, reinforcing the need for replication.

Participation itself was limited. Among people with available platform logs, average module completion was 37.9%, and 18% never accessed a module. Audio use was not captured, so these records could not fully measure mindfulness practice.

Who Was Included Also Shapes the Answer

The trial excluded people already receiving cannabis treatment, those with pharmacologically treated psychiatric disorders, and people reporting current suicidal thoughts, among other criteria. Its findings therefore cannot automatically extend to everyone seeking help.

This connects with the broader question explored in more inclusive cannabis clinical trials: eligibility and recruitment determine whose experiences become evidence. A future programme combining digital exercises with professional support would need its own evaluation in more complex populations.

Why This Is Not Evidence That Meditation Alone Works

A separate 2025 randomized trial of brief mindfulness training enrolled 66 adults with cannabis use disorder and found no significant advantage for cannabis frequency, quantity, or cravings. Its intervention lasted roughly 16 days, making it substantially different from the six-week CANreduce package and its longer follow-up.

The contrast does not establish that longer training explains the difference. Duration, programme content, participants, and comparison conditions all varied. It does show why “mindfulness works” is too broad a conclusion.

A 2025 review of psychosocial cannabis treatments, covering 22 randomized trials, likewise found encouraging results for some approaches but rated the evidence as low or very low certainty. The new trial adds a useful piece to that developing picture.

Measuring Progress Beyond Cannabis-Use Days

Counting consumption days makes comparison straightforward, but it cannot fully describe someone’s health. Fewer days do not necessarily mean lower THC exposure, fewer difficulties at work, or improved relationships.

MyCannabis’s coverage of daily functioning in cannabis research raises a related measurement issue in a different population: a single headline score cannot capture every meaningful outcome. Here, improvements in mood and cannabis-related problems help broaden the picture, without establishing recovery.

Future trials could make progress clearer by examining:

  • Whether benefits persist beyond six months.
  • Whether daily functioning improves alongside consumption patterns.
  • Whether human support improves engagement and follow-up.

Safety reporting also deserves attention. At six weeks, 24 of 156 respondents reported at least one negative effect they attributed to the programme, including psychological distress among the described experiences. Digital self-help should not be assumed universally comfortable or suitable, and this study does not establish it as a replacement for individualized care.

The Next Test for Digital Cannabis Support

The practical promise is flexible support that people can revisit when they need it. Yet availability and sustained participation are different achievements. This trial suggests that adding mindfulness to structured cannabis self-help may improve durability, while exposing how much remains unknown when engagement and follow-up are low.

The next decisive step is a larger trial with stronger retention, better measurement of actual practice, and longer observation. If the advantage holds, researchers will have a firmer basis for identifying which components help, whom they help, and how to deliver them reliably.

References:

1 Boumparis, N., Haug, S., Baumgartner, C., Wenger, A., Malischnig, D., Dey, M., & Schaub, M. P. (2026). Added value of mindfulness in a digital cannabis intervention: Three-arm randomized trial. Internet Interventions, 46, 101021. https://doi.org/10.1016/j.invent.2026.101021

Maya Bennett trouve de nombreuses choses à explorer dans les aspects du quotidien liés au cannabis : une étiquette peu familière, une conversation gênante ou une question que personne n’a pensé à poser. Sur MyCannabis.com, elle écrit sur les produits, les gens et l’évolution des mentalités, avec curiosité et un ton accueillant pour aborder un sujet qui peut encore sembler intimidant.